40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
11.73%
Cash & equivalents yoy growth 1.25-1.5x VET's 8.72%. Bruce Berkowitz would examine if higher cash accumulation is strategic or just idle.
No Data
No Data available this quarter, please select a different quarter.
11.73%
Cash + STI yoy 1.25-1.5x VET's 8.72%. Bruce Berkowitz would check if the firm is preparing for expansions or simply hoarding.
-14.94%
Receivables growth less than half of VET's 11.37%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
107.58%
Inventory growth above 1.5x VET's 8.91%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
-17.26%
Other current assets growth < half of VET's 10.38%. David Dodd sees a leaner approach to short-term items.
0.16%
Below half of VET's 8.92%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
2.69%
0.75-0.9x VET's 3.16%. Bill Ackman questions if competitor invests more heavily in future capacity.
1.57%
Higher Goodwill Growth compared to VET's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
1.57%
Higher Goodwill + Intangibles Growth compared to VET's zero value, indicating worse performance.
-6.36%
Both VET and the company show zero Long-Term Investments Growth.
-5.70%
Less than half of VET's 1.21%. David Dodd sees fewer tax deferrals or losses, indicating stronger profitability vs. competitor.
0.56%
Higher Other Non-Current Assets Growth compared to VET's zero value, indicating worse performance.
1.61%
0.5-0.75x VET's 3.03%. Martin Whitman wonders if there's insufficient reinvestment vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
1.21%
Below half of VET's 3.80%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-2.57%
Less than half of VET's 21.04%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
75.00%
Above 1.5x VET's 15.18%. Michael Burry questions if there's an abrupt jump in tax obligations or poor payment scheduling.
-14.75%
Both VET and the company show zero Deferred Revenue (Current) Growth.
-96.08%
Less than half of VET's 10667.59%. David Dodd sees fewer expansions in other current obligations.
0.98%
Less than half of VET's 19.59%. David Dodd sees a more disciplined short-term liability approach.
0.26%
Above 1.5x VET's 0.08%. Michael Burry suspects significant leverage additions. Check coverage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.06%
Above 1.5x VET's 1.13%. Michael Burry suspects a looming risk from large additions to LT liabilities.
0.87%
Above 1.5x VET's 0.56%. Michael Burry sees a strong spike vs. competitor. Check coverage and debt ratios.
No Data
No Data available this quarter, please select a different quarter.
0.89%
Less than half of VET's 4.07%. David Dodd sees far fewer liability expansions relative to competitor.
1.75%
1.25-1.5x VET's 1.22%. Martin Whitman sees potential dilution risk vs. competitor approach.
1.77%
Below half VET's 9.47%. Michael Burry suspects major net losses or high dividends vs. competitor.
3.62%
Less than half of VET's 98.88%. David Dodd sees fewer intangible or market-driven swings than competitor.
-1.08%
Higher Other Stockholders' Equity Items Growth compared to VET's zero value, indicating worse performance.
1.98%
0.5-0.75x VET's 3.49%. Martin Whitman is wary of lagging equity growth vs. competitor.
1.21%
Below half VET's 3.80%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
-6.36%
Both VET and the company show zero Total Investments Growth.
0.50%
Above 1.5x VET's 0.08%. Michael Burry sees a major jump. Investigate leverage rationale.
-4.58%
1.25-1.5x VET's -3.66%. Martin Whitman is wary of heavier net leverage vs. competitor.
